The United States leads the Gastrointestinal Infection Testing market in North America, driven by a high burden of foodborne and healthcare-associated infections caused by pathogens such as Clostridioides difficile, Salmonella, norovirus, and E. coli. The country benefits from a well-established clinical laboratory network, rapid adoption of molecular and multiplex PCR-based syndromic panels, and the strong presence of major diagnostic companies investing in faster, more accurate detection technologies.

According to The Insight Partners, Global Gastrointestinal Infection Testing Market size is projected to reach US$ 3,179.74 million by 2034 from US$ 1,610.84 million in 2025. The market is anticipated to register a CAGR of 7.85% during the forecast period 2026-2034.

The gastrointestinal infection testing market is experiencing significant growth, fueled by the increasing prevalence of infectious gastrointestinal diseases, rising demand for rapid and accurate diagnostic solutions, and ongoing advancements in molecular diagnostic technologies. The market continues to gain momentum as healthcare providers emphasize early pathogen detection to improve patient outcomes. Growing adoption of advanced testing methods for identifying bacterial, viral, and parasitic infections is expected to further drive market expansion over the forecast period.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00002767

The gastrointestinal infection testing market is witnessing robust expansion driven by the rising global burden of infectious diseases, increasing demand for rapid diagnostics, and continuous technological innovation in molecular testing platforms. The market’s growth trajectory reflects the increasing importance of early and accurate detection of pathogens responsible for gastrointestinal infections, including bacteria, viruses, and parasites.

One of the primary drivers of market growth is the increasing adoption of molecular diagnostic technologies. Polymerase chain reaction (PCR), multiplex testing panels, and next-generation sequencing (NGS) have revolutionized infectious disease detection by enabling simultaneous identification of multiple pathogens in a single test. These technologies reduce diagnostic turnaround time, improve accuracy, and support timely clinical decision-making. Healthcare providers are increasingly transitioning from traditional culture-based methods to molecular diagnostics due to their superior sensitivity and specificity.

Another major market driver is the rising global incidence of foodborne diseases. According to health organizations, millions of people suffer from food contamination-related infections each year, leading to significant economic and healthcare burdens. This has prompted governments and healthcare institutions to invest in better surveillance and testing infrastructure. Increasing consumer awareness regarding food safety and hygiene has also contributed to higher demand for routine testing, especially in hospitals, diagnostic laboratories, and food safety testing facilities.

Healthcare infrastructure improvements and increased healthcare spending in developing countries are also contributing to market expansion. Governments across Asia-Pacific, Latin America, and the Middle East are strengthening laboratory capabilities and expanding access to advanced diagnostic technologies. These initiatives are encouraging adoption of innovative testing solutions and expanding the customer base for diagnostic companies.

Increasing investments in research and development by diagnostic companies are accelerating innovation in the market. Companies are focusing on developing multiplex panels capable of detecting a broad range of pathogens in a single test. Automation and integration of artificial intelligence in diagnostic workflows are further enhancing laboratory efficiency and reducing human error.

Gastrointestinal Infection Testing Market Segmentation

Test Type

Laboratory Tests
Imaging Tests
Biopsy
Technique

Conventional Techniques
Molecular Techniques
Biochemical Techniques
End User

Hospitals
Diagnostic Imaging Centers and Laboratories
Ambulatory Surgical Centers
Academic Institutes
Research Organizations
Geography

North America
Europe
Asia-Pacific
South and Central America
Middle East and Africa
Competitive Landscape and Key Players

The gastrointestinal infection testing market is highly competitive, with leading diagnostic companies focusing on product innovation, strategic partnerships, and global expansion. Major players operating in the market include:

BD
Savyon Diagnostics
Biomérieux Sa
Nanoentek Inc.
Luminex Corporation
Hologic Inc.
Bio-Rad Laboratories, Inc.
Trinity Biotech
Quest Diagnostics Incorporated.
Alere
Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Quidel Corporation
Illumina, Inc.
These companies are investing heavily in molecular diagnostics, automation, and rapid testing technologies to strengthen their market positions and meet evolving healthcare demands.

Regional Outlook

North America currently holds a significant share of the gastrointestinal infection testing market due to advanced healthcare infrastructure, high awareness of infectious diseases, and strong presence of leading diagnostic companies. Europe follows closely, supported by government initiatives focused on disease surveillance and infection control. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth during the forecast period due to rising healthcare expenditure, increasing population, and expanding laboratory infrastructure.

Future Outlook

The future of the gastrointestinal infection testing market looks promising, with strong growth expected across all major regions. Continuous innovation in molecular diagnostics, expansion of point-of-care testing, and increasing awareness of infectious diseases will remain the key drivers shaping market growth through 2034. As healthcare systems worldwide prioritize early detection and prevention of infectious diseases, the demand for advanced gastrointestinal infection testing solutions is set to rise steadily.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
E-mail: [email protected]
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish